Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2014-09-11 02:05:33 UTC |
---|
Update Date | 2016-11-09 01:09:11 UTC |
---|
Accession Number | CHEM003658 |
---|
Identification |
---|
Common Name | Lomustine |
---|
Class | Small Molecule |
---|
Description | Lomustine is only found in individuals that have used or taken this drug. It is an alkylating agent of value against both hematologic malignancies and solid tumors. Lomustine is a highly lipophilic nitrosourea compound which undergoes hydrolysis in vivo to form reactive metabolites. These metabolites cause alkylation and cross-linking of DNA (at the O6 position of guanine-containing bases) and RNA, thus inducing cytotoxicity. Other biologic effects include inhibition of DNA synthesis and some cell cycle phase specificity. Nitrosureas generally lack cross-resistance with other alkylating agents. As lomustine is a nitrosurea, it may also inhibit several key processes such as carbamoylation and modification of cellular proteins. |
---|
Contaminant Sources | - HMDB Contaminants - Urine
- IARC Carcinogens Group 2A
- STOFF IDENT Compounds
- T3DB toxins
- ToxCast & Tox21 Chemicals
|
---|
Contaminant Type | - Amine
- Antineoplastic Agent, Alkylating
- Drug
- Metabolite
- Organic Compound
- Organochloride
- Synthetic Compound
|
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea | ChEBI | 1-(2-Chloroethyl)-3-cyclohexylnitrosourea | ChEBI | Belustine | ChEBI | CCNU | ChEBI | Cecenu | ChEBI | CeeNU | ChEBI | Chloroethylcyclohexylnitrosourea | ChEBI | CINU | ChEBI | Cyclohexyl chloroethyl nitrosourea | ChEBI | Lomustina | ChEBI | Lomustinum | ChEBI | N-(2-Chloroethyl)-n'-cyclohexyl-N-nitrosourea | ChEBI | Gleostine | Kegg | Bristol-myers squibb brand OF lomustine | HMDB | Rhône-poulenc rorer brand OF lomustine | HMDB | Medac brand OF lomustine | HMDB | Bristol myers squibb brand OF lomustine | HMDB | Rhône poulenc rorer brand OF lomustine | HMDB | Lomustine medac brand | HMDB |
|
---|
Chemical Formula | C9H16ClN3O2 |
---|
Average Molecular Mass | 233.695 g/mol |
---|
Monoisotopic Mass | 233.093 g/mol |
---|
CAS Registry Number | 13010-47-4 |
---|
IUPAC Name | 3-(2-chloroethyl)-1-cyclohexyl-3-nitrosourea |
---|
Traditional Name | lomustine |
---|
SMILES | ClCCN(N=O)C(=O)NC1CCCCC1 |
---|
InChI Identifier | InChI=1S/C9H16ClN3O2/c10-6-7-13(12-15)9(14)11-8-4-2-1-3-5-8/h8H,1-7H2,(H,11,14) |
---|
InChI Key | GQYIWUVLTXOXAJ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as nitrosoureas. Nitrosoureas are compounds containing a nitro group and an urea group N-N linked together, with the general structure R1N(R2)C(=O)N(R3)N=O. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Organic carbonic acids and derivatives |
---|
Sub Class | Ureas |
---|
Direct Parent | Nitrosoureas |
---|
Alternative Parents | |
---|
Substituents | - Nitrosourea
- Semicarbazide
- Nitrosamide
- Organic n-nitroso compound
- Organic nitroso compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Alkyl chloride
- Organooxygen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Carbonyl group
- Alkyl halide
- Organic nitrogen compound
- Aliphatic homomonocyclic compound
|
---|
Molecular Framework | Aliphatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | White powder. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | 88 - 90°C | Boiling Point | Not Available | Solubility | 111 mg/L |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-0059-8900000000-edefb2c60fb3a4723f1b | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-003r-9870000000-c1e5d9089d0ca3ebe990 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-004j-9600000000-553a8bea32ca95f8b8c9 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-03di-9000000000-237df2753e3c79610270 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-05aj-4940000000-52228cb236f776094d55 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0002-9520000000-f52d4c064b87d135bcab | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0002-9100000000-c986da9a3b5f2025b30c | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03e9-9410000000-3c91b816a1fd60d9fb41 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03e9-9100000000-e9795a3320548e7e0520 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-001i-9000000000-13ca0d883f27e08e4efe | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-001i-3190000000-21d4dc32f394af73cd0d | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-001i-9000000000-99ed100e7c6291a96d1b | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-001i-9000000000-7fe5321df11e6429faf4 | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Well and rapidly absorbed from the gastrointestinal tract. |
---|
Mechanism of Toxicity | Lomustine is a highly lipophilic nitrosourea compound which undergoes hydrolysis in vivo to form reactive metabolites. These metabolites cause alkylation and cross-linking of DNA (at the O6 position of guanine-containing bases) and RNA, thus inducing cytotoxicity. Other biologic effects include inhibition of DNA synthesis and some cell cycle phase specificity. Nitrosureas generally lack cross-resistance with other alkylating agents. As lomustine is a nitrosurea, it may also inhibit several key processes such as carbamoylation and modification of cellular proteins. |
---|
Metabolism | Hepatic. Rapid and complete, with active metabolites.
Route of Elimination: Following oral administration of radioactive CeeNU at doses ranging from 30 mg/m2 to 100 mg/m2, about half of the radioactivity given was excreted in the urine in the form of degradation products within 24 hours.
Half Life: Approximately 94 minutes, however the metabolites have a serum half-life of 16 to 48 hours. |
---|
Toxicity Values | Oral, rat: LD50 = 70 mg/kg. Pulmonary toxicity has been reported at cumulative doses usually greater than 1,100 mg/m2. There is one report of pulmonary toxicity at a cumulative dose of only 600 mg. The onset of toxicity has varied from 6 months after initiation of therapy, to as late as 15 years after. |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | 2A, probably carcinogenic to humans. (1) |
---|
Uses/Sources | For the treatment of primary and metastatic brain tumors as a component of combination chemotherapy in addition to appropriate surgical and/or radiotherapeutic procedures. Also used in combination with other agents as secondary therapy for the treatment of refractory or relapsed Hodgkin's disease. |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DB01206 |
---|
HMDB ID | HMDB0015337 |
---|
FooDB ID | Not Available |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Lomustine |
---|
Chemspider ID | 3813 |
---|
ChEBI ID | 6520 |
---|
PubChem Compound ID | 3950 |
---|
Kegg Compound ID | C07079 |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Link |
---|
General References | |
---|